BIOMAT Database Logo BIOMAT Database Logo

Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis. 2004

Chien-Yi Chen, and Po-Nien Tsao, and Huey-Ling Chen, and Hung-Chieh Chou, and Wu-Shiun Hsieh, and Mei-Hwei Chang
Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, No. 7 Chung-Shan South Road, Taipei 100, Taiwan.

OBJECTIVE To determine the effect of ursodeoxycholic acid (UDCA) in very-low-birth-weight (VLBW) infants with parenteral nutrition-associated cholestasis (PNAC). METHODS A retrospective study of all VLBW infants with PNAC who were admitted to a tertiary referral center was conducted. Patients were classified as treatment group (receiving UDCA within 14 days after onset of cholestasis) or control group (no medical treatment). Patients who received abdominal surgery were excluded. RESULTS A total of 30 patients were recruited, including 12 in the treatment group and 18 in the control group. The demographic data, total fasting duration, onset of cholestasis, age to tolerance of full feeds, and the duration of parenteral nutrition (PN) before the onset of cholestasis were comparable between the two groups. There was a trend in the control group to later onset of cholestasis. The patients who received UDCA therapy with doses of 10 to 30 mg/kg/day had a shorter duration of cholestasis than the control group (62.8 vs 92.4 days, P=.006). Furthermore, the peak serum levels of direct bilirubin also was significantly lower in the treatment group. CONCLUSIONS UDCA can improve the course of PNAC in VLBW infants.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D010288 Parenteral Nutrition The administering of nutrients for assimilation and utilization by a patient who cannot maintain adequate nutrition by enteral feeding alone. Nutrients are administered by a route other than the alimentary canal (e.g., intravenously, subcutaneously). Intravenous Feeding,Nutrition, Parenteral,Parenteral Feeding,Feeding, Intravenous,Feeding, Parenteral,Feedings, Intravenous,Feedings, Parenteral,Intravenous Feedings,Parenteral Feedings
D001724 Birth Weight The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms. Birthweight,Birth Weights,Birthweights,Weight, Birth,Weights, Birth
D002779 Cholestasis Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS). Bile Duct Obstruction,Biliary Stasis,Bile Duct Obstructions,Biliary Stases,Cholestases,Duct Obstruction, Bile,Duct Obstructions, Bile,Obstruction, Bile Duct,Obstructions, Bile Duct,Stases, Biliary,Stasis, Biliary
D005260 Female Females
D005865 Gestational Age The age of the conceptus, beginning from the time of FERTILIZATION. In clinical obstetrics, the gestational age is often estimated from the onset of the last MENSTRUATION which is about 2 weeks before OVULATION and fertilization. It is also estimated to begin from fertilization, estrus, coitus, or artificial insemination. Embryologic Age,Fetal Maturity, Chronologic,Chronologic Fetal Maturity,Fetal Age,Maturity, Chronologic Fetal,Age, Embryologic,Age, Fetal,Age, Gestational,Ages, Embryologic,Ages, Fetal,Ages, Gestational,Embryologic Ages,Fetal Ages,Gestational Ages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001663 Bilirubin A bile pigment that is a degradation product of HEME. Bilirubin IX alpha,Bilirubin, (15E)-Isomer,Bilirubin, (4E)-Isomer,Bilirubin, (4E,15E)-Isomer,Bilirubin, Calcium Salt,Bilirubin, Disodium Salt,Bilirubin, Monosodium Salt,Calcium Bilirubinate,Hematoidin,delta-Bilirubin,Bilirubinate, Calcium,Calcium Salt Bilirubin,Disodium Salt Bilirubin,Monosodium Salt Bilirubin,Salt Bilirubin, Calcium,delta Bilirubin

Related Publications

Chien-Yi Chen, and Po-Nien Tsao, and Huey-Ling Chen, and Hung-Chieh Chou, and Wu-Shiun Hsieh, and Mei-Hwei Chang
Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants.
February 2006, Singapore medical journal,
Chien-Yi Chen, and Po-Nien Tsao, and Huey-Ling Chen, and Hung-Chieh Chou, and Wu-Shiun Hsieh, and Mei-Hwei Chang
Parenteral Nutrition-Associated Cholestasis in Very Low Birth Weight Infants: A Single Center Experience.
March 2016, Pediatric gastroenterology, hepatology & nutrition,
Chien-Yi Chen, and Po-Nien Tsao, and Huey-Ling Chen, and Hung-Chieh Chou, and Wu-Shiun Hsieh, and Mei-Hwei Chang
[High-risk factors for parenteral nutrition-associated cholestasis in very low birth weight infants].
October 2012, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics,
Chien-Yi Chen, and Po-Nien Tsao, and Huey-Ling Chen, and Hung-Chieh Chou, and Wu-Shiun Hsieh, and Mei-Hwei Chang
Parenteral Nutrition in Very Low Birth Weight Preterm Infants.
May 2015, The Israel Medical Association journal : IMAJ,
Chien-Yi Chen, and Po-Nien Tsao, and Huey-Ling Chen, and Hung-Chieh Chou, and Wu-Shiun Hsieh, and Mei-Hwei Chang
Ursodeoxycholic Acid and SMOFlipid for Treating Parenteral Nutrition Associated Cholestasis in Infants.
February 2022, Cureus,
Chien-Yi Chen, and Po-Nien Tsao, and Huey-Ling Chen, and Hung-Chieh Chou, and Wu-Shiun Hsieh, and Mei-Hwei Chang
Plasma amino acid patterns in very low birth weight infants during parenteral nutrition.
January 1990, Indian journal of pediatrics,
Chien-Yi Chen, and Po-Nien Tsao, and Huey-Ling Chen, and Hung-Chieh Chou, and Wu-Shiun Hsieh, and Mei-Hwei Chang
[Parenteral and enteral nutrition for low-birth-weight and very low-birth-weight infants].
November 1991, Nihon rinsho. Japanese journal of clinical medicine,
Chien-Yi Chen, and Po-Nien Tsao, and Huey-Ling Chen, and Hung-Chieh Chou, and Wu-Shiun Hsieh, and Mei-Hwei Chang
Risk factor analysis of parenteral nutrition-associated cholestasis in extremely low birth weight infants.
July 2016, Acta paediatrica (Oslo, Norway : 1992),
Chien-Yi Chen, and Po-Nien Tsao, and Huey-Ling Chen, and Hung-Chieh Chou, and Wu-Shiun Hsieh, and Mei-Hwei Chang
Plasma Phytosterol Half-Life and Levels Are Increased in Very Low Birth Weight Preterm Infants with Parenteral Nutrition-Associated Cholestasis.
July 2018, Lipids,
Chien-Yi Chen, and Po-Nien Tsao, and Huey-Ling Chen, and Hung-Chieh Chou, and Wu-Shiun Hsieh, and Mei-Hwei Chang
Aggressive nutrition in extremely low birth weight infants: impact on parenteral nutrition associated cholestasis and growth.
January 2016, PeerJ,
Copied contents to your clipboard!